sodium chloride
- Product NDC
- 64253-202
- 11-digit product format
- 642530202
- Labeler code
- 64253
- Product ID
- 64253-202_4bbe9ad8-075c-216b-e063-6294a90a1024
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- SODIUM CHLORIDE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Medefil, Inc.
- Application
- NDA202832
- Marketing category
- NDA
- Marketing start
- 2012-01-13
- Substance
- SODIUM CHLORIDE
- Active strength
- 9 mg/mL
- Pharmacologic classes
- Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- sodium chloride
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SODIUM CHLORIDE | 9 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 451W47IQ8X |
| Rxcui | 727820 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 64253-202-30 | 2024-03-05 | C162847 | 48780-1 | ba0f9c33-4167-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use SODIUM CHLORIDE INJECTION, USP, 0.9% safely and effectively. See full prescribing information for SODIUM CHLORIDE INJECTION, USP, 0.9%. SODIUM CHLORIDE INJECTION, USP, 0.9% Initial U.S. Approval: 2012 |
| 64253-202-30 | 2024-01-30 | C162847 | 48780-1 | ba0f9c33-4167-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use SODIUM CHLORIDE INJECTION, USP, 0.9% safely and effectively. See full prescribing information for SODIUM CHLORIDE INJECTION, USP, 0.9%. SODIUM CHLORIDE INJECTION, USP, 0.9% Initial U.S. Approval: 2012 |
| 64253-202-30 | 2021-03-03 | C162847 | 48780-1 | ba0f9c33-4167-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use SODIUM CHLORIDE INJECTION, USP, 0.9% safely and effectively. See full prescribing information for SODIUM CHLORIDE INJECTION, USP, 0.9%. SODIUM CHLORIDE INJECTION, USP, 0.9% Initial U.S. Approval: 2012 |
| 64253-202-30 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4167-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use SODIUM CHLORIDE INJECTION, USP, 0.9% safely and effectively. See full prescribing information for SODIUM CHLORIDE INJECTION, USP, 0.9%. SODIUM CHLORIDE INJECTION, USP, 0.9% Initial U.S. Approval: 2012 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 64253-202-30 | sodium chloride | 10 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 10 | | 21 |
| 64253-202-30 | sodium chloride | 60 in 1 BOX | INJECTION, SOLUTION | 60 | | 21 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 64253-202 | SODIUM CHLORIDE INJECTION, SOLUTION [MEDEFIL, INC.] | 20 | Current NDC, Legacy NDC, 2 package rows | 20240307_d1468c0f-dd4f-4d38-a84c-c1d110303965.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 64253-202-30 | 64253020230 | 60 SYRINGE, PLASTIC in 1 BOX (64253-202-30) / 10 mL in 1 SYRINGE, PLASTIC | 2012-01-13 | 0000-00-00 | No | No | Current |